Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, below historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-22.61M
↓ 118% below average
Average (9y)
$124.38M
Historical baseline
Range
High:$807.08M
Low:$-22.61M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-22.61M | -289.3% |
| 2023 | $11.94M | +293.2% |
| 2022 | $3.04M | -97.1% |
| 2021 | $103.85M | +176.9% |
| 2020 | $37.50M | -95.4% |
| 2019 | $807.08M | +392.9% |
| 2018 | $163.73M | +140.5% |
| 2017 | $68.08M | +55.1% |
| 2016 | $43.88M | +60.6% |
| 2015 | $27.33M | - |